1. Chicken cathelicidin-2-derived peptides with enhanced immunomodulatory and antibacterial activities against biological warfare agents
- Author
-
Floris J. Bikker, Roos H. Mars-Groenendijk, Helma Dijk-Knijnenburg, Edwin J.A. Veldhuizen, Linda C.L. Boele, Albert van Dijk, Wendy Esmeralda Kaman-Van Zanten, Henk P. Haagsman, E. Margo Molhoek, Strategic Infection Biology, LS Moleculaire Afweer, I&I SIB3, TNO Defensie en Veiligheid, Faculty of Veterinary Medicine, Utrecht University [Utrecht], Department of Oral Biochemistry, Vrije Universiteit Amsterdam [Amsterdam] (VU), and Orale Biochemie (OUD, ACTA)
- Subjects
Lipopolysaccharides ,Methicillin-Resistant Staphylococcus aureus ,Microbiology (medical) ,Immunomodulatory activity ,Yersinia pestis ,Cytotoxicity ,medicine.medical_treatment ,Colony Count, Microbial ,Biological Warfare Agents ,Peptide ,Biology ,medicine.disease_cause ,Microbiology ,Cathelicidin ,Biological warfare agents ,medicine ,Animals ,Humans ,Immunologic Factors ,Pharmacology (medical) ,Vibrio cholerae ,Antibacterial agent ,chemistry.chemical_classification ,Microbial Viability ,Defence ,Pathogenic bacteria ,Biological activity ,General Medicine ,biology.organism_classification ,Anti-Bacterial Agents ,Bacillus anthracis ,Host defence peptide ,Infectious Diseases ,Amino Acid Substitution ,Biochemistry ,chemistry ,Leukocytes, Mononuclear ,Cytokines ,Antibacterial activity ,Chickens ,Antimicrobial Cationic Peptides - Abstract
Host defence peptides (HDPs) are considered to be excellent candidates for the development of novel therapeutic agents. Recently, it was demonstrated that the peptide C1-15, an N-terminal segment of chicken HDP cathelicidin-2, exhibits potent antibacterial activity while lacking cytotoxicity towards eukaryotic cells. In the present study, we report that C1-15 is active against bacteria such as Bacillus anthracis and Yersinia pestis that may potentially be used by bioterrorists. Substitution of single and multiple phenylalanine (Phe) residues to tryptophan (Trp) in C1-15 resulted in variants with improved antibacterial activity against B. anthracis and Y. pestis as well as decreased salt sensitivity. In addition, these peptides exhibited enhanced neutralisation of lipopolysaccharide (LPS)-induced release of pro-inflammatory cytokines in human peripheral blood mononuclear cells (PBMCs). The antibacterial and LPS-neutralising activities of these C1-15-derived peptides are exerted at concentrations far below the concentrations that are toxic to human PBMCs. Taken together, we show that Phe → Trp substitutions in C1-15 variants enhances the antibacterial and LPS-neutralising activities against pathogenic bacteria, including those that may potentially be used as biological warfare agents.Keywords: Host defence peptide; Cathelicidin; Antibacterial activity; Cytotoxicity; Immunomodulatory activity; Biological warfare agents
- Published
- 2010
- Full Text
- View/download PDF